Media More Coverage

Einstein in the Media

The Wall Street Journal features comments from Roman Perez-Soler, M.D., regarding research that linked the cancer drug Avastin to a higher rate of life-threatening side effects when used to treat certain cancer types, such as pancreatic or breast cancer, for which the drug is not approved. Dr. Perez-Soler notes the study does not advise that Avastin should no longer be prescribed for certain cancer patients and that he still uses the drug to treat his patients with lung cancer, for which the drug is approved. Dr. Perez-Soler is professor of medicine at Einstein and chief of oncology at the Montefiore-Einstein Center for Cancer Care. (Wednesday, February 02, 2011)

More coverage on this story

U.S. News & World Report (via Healthday)

 

U.S. News & World Report (via Healthday) features comments by Roman Perez-Soler, M.D., on an experimental cancer drug that is proving effective in treating some lung cancers. A recently released study showed that the drug, crizotinib, seemed to work well in patients whose tumors had a specific genetic mutation. Dr. Perez-Soler notes that while this is promising, there could be so many different genotypes that it would be impractical to come up with drugs targeting all of them. Dr. Perez-Soler is professor of medicine at Einstein and chief of oncology at the Montefiore-Einstein Center for Cancer Care. (Wednesday, October 27, 2010)

More coverage on other stories